Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Imatinib Mesylate 3 nilotinib 2 Sunitinib 2 Ibandronic Acid 2 Doxorubicin 2 Cyclophosphamide 2 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 nirogacestat 1 avapritinib 1 anlotinib 1 Zoledronic Acid 1 Tranexamic Acid 1 Thiotepa 1 Ritonavir 1 Radiotherapy 1 Pregabalin 1 Oxaliplatin 1 Nevirapine 1 Midazolam 1 Lopinavir 1 Lithium Carbonate 1 Lead 1 Kyphoplasty 1 Indocyanine Green 1 Ifosfamide 1 Hyperbaric Oxygenation 1 Filgrastim 1 Esomeprazole 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lopinavir × Sarcoma × Clear all

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡